ITOS News & Events

Vor Bio (VOR) announced the appointment of Adi Osovsky, S.J.D. as General Counsel. Dr. Osovsky brings 17 years of corporate counsel and law firm experience in the biotechnology and pharmaceutical sectors. Dr. Osovsky joins Vor Bio from iTeos Therapeutics (ITOS), where she served as Executive Vice President, Head of Legal & Corporate Secretary.

Vor Bio (VOR) announced the appointment of Alexander Cumbo and Michel Detheux, Ph.D., to its Board of Directors, effective July 16, 2025. Alexander Cumbo currently serves as President and Chief Executive Officer of Solid Biosciences (SLDB). Michel Detheux, Ph.D., is President and Chief Executive Officer of iTeos Therapeutics (ITOS)